Abbott Laboratories (NYSE:ABT) Sees Significant Decrease in
Abbott Laboratories (NYSE:ABT) Sees Significant Decrease in Short Interest
Abbott Laboratories (NYSE:ABT – Get Free Report) was the target of a significant decline in short interest in September. As of September 15th, there was short interest totalling 10,610,000 shares, a decline of 7.5% from the August 31st total of 11,470,000 shares. Based on an average daily trading volume, of 4,450,000 shares, the days-to-cover ratio […]
Related Keywords
Andreaf Wainer, Danielj Starks, , Cornerstone Planning Group, Morgan Stanley, Citigroup, Financial Services, Monumental Financial Group Inc, Jefferies Financial Group, Barclays, Abbott Laboratories, Investment Management, Abbott Laboratories Company Profile, Altshuler Shaham Ltd, Get Free Report, Director Daniel, Shaham Ltd, Planning Group, Financial Group, Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, Abbott Laboratories Daily, Nyse Abt, Abt, Medical, 00282410, Stocks, Options, Put, Call,